Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Toxicology|October 2, 2004
In silico tools to aid risk assessment of endocrine disrupting chemicalsM N JacobsThe Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structureM N Jacobs, M Dickins, D F V LewisHuman & Experimental Toxicology|July 10, 2002
Human carcinogens: an evaluation study via the COMPACT and HazardExpert proceduresD F V Lewi, M G Bird, M N JacobsRegulatory Toxicology and Pharmacology : RTP|July 16, 2017
Biometrical evaluation of the performance of the revised OECD Test Guideline 402 for assessing acute dermal toxicityH Mielke, J Strickland, M N Jacobs, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 22, 2002
Molecular modelling of the peroxisome proliferator-activated receptor alpha (PPAR alpha) from human, rat and mouse, based on homology with the human PPAR gamma crystal structureD F V Lewis, M N Jacobs, M Dickins, et al.Toxicology|June 14, 2002
Quantitative structure--activity relationships for inducers of cytochromes P450 and nuclear receptor ligands involved in P450 regulation within the CYP1, CYP2, CYP3 and CYP4 familiesD F V Lewis, M N Jacobs, M Dickins, et al.Chemosphere|November 26, 1998
Organochlorine residues in fish oil dietary supplements: comparison with industrial grade oilsM N Jacobs, D Santillo, P A Johnston, et al.Regulatory Toxicology and Pharmacology : RTP|September 1, 2020
Building confidence in skin sensitisation potency assessment using new approach methodologies: report of the 3rd EPAA Partners Forum, Brussels, 28th October 2019D Basketter, S Beken, H Bender, et al.Current Drug Metabolism|October 16, 2008
The use of metabolising systems for in vitro testing of endocrine disruptorsM N Jacobs, W Janssens, U Bernauer, et al.Pageof 1